| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.25 | 9e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |